Literature DB >> 12368223

Chromosome 6 suffers frequent and multiple aberrations in thymoma.

Masayoshi Inoue1, Alexander Marx, Andreas Zettl, Philipp Ströbel, Hans-Konrad Müller-Hermelink, Petr Starostik.   

Abstract

Thymoma is the most frequent tumor arising in human thymus. In this study, we performed a detailed mapping of deleted regions on chromosome 6 shown previously to harbor the most frequent genetic aberrations in this cancer. We analyzed 40 thymomas using 41 microsatellites. Two hundred ninety-four (23.5%) of 1253 informative genotypes showed loss of heterozygosity (LOH), only 39 (2.4%) were positive for microsatellite instability (MSI). Genetic aberrations on chromosome 6 were found in 31 of 40 cases (77.5%) in five hot spots. The most frequent LOHs (48.6%) occurred in region 6q25.2 within a 0.7-Mb interval flanked by markers D6S441 and D6S290. Another hot spot showing LOH in 32.4% of tumors was located between markers D6S442 and D6S1708 (0.4 Mb apart) on 6q25.2-25.3, just 1.1 Mb from the D6S441-D6S290 deletions. The third hot spot (30%) showing LOH appeared in region 6p21.31 including the MHC locus (markers D6S1666-D6S1560, 1 Mb apart). The fourth hot spot (26.3%) was detected on 6q14.1-14.3 (D6S1596-D6S284, 5.2 Mb apart). Some tumors (21.6%) showed LOHs within a fifth hot spot on 6q21 (D6S447-D6S1592, 0.3 Mb apart). Thus, several tumor suppressor genes on chromosome 6 seem to be involved in the pathogenesis of thymoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368223      PMCID: PMC1867301          DOI: 10.1016/S0002-9440(10)64426-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus.

Authors:  Y Fukui; T Ishimoto; M Utsuyama; T Gyotoku; T Koga; K Nakao; K Hirokawa; M Katsuki; T Sasazuki
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

2.  Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma.

Authors:  D W Bell; S C Jhanwar; J R Testa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

3.  Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.

Authors:  B C Bastian; P E LeBoit; H Hamm; E B Bröcker; D Pinkel
Journal:  Cancer Res       Date:  1998-05-15       Impact factor: 12.701

Review 4.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.

Authors:  M Theile; S Seitz; W Arnold; B Jandrig; R Frege; P M Schlag; W Haensch; H Guski; K J Winzer; J C Barrett; S Scherneck
Journal:  Oncogene       Date:  1996-08-15       Impact factor: 9.867

Review 6.  Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma.

Authors:  H K Müller-Hermelink; A Wilisch; A Schultz; A Marx
Journal:  Arch Histol Cytol       Date:  1997-03

7.  Recurrent genetic aberrations in thymoma and thymic carcinoma.

Authors:  A Zettl; P Ströbel; K Wagner; T Katzenberger; G Ott; A Rosenwald; K Peters; A Krein; M Semik; H K Müller-Hermelink; A Marx
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Identification of allelic loss on chromosome arm 6p in human astrocytomas by arbitrarily primed polymerase chain reaction.

Authors:  Y Saitoh; J M Bruner; V A Levin; A P Kyritsis
Journal:  Genes Chromosomes Cancer       Date:  1998-07       Impact factor: 5.006

9.  The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21.

Authors:  A Jackson; P Panayiotidis; L Foroni
Journal:  Genomics       Date:  1998-05-15       Impact factor: 5.736

10.  Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4-CD8- cells to CD4+CD8+ cells in vitro.

Authors:  M Inoue; Y Fujii; M Okumura; Y Takeuchi; H Shiono; S Miyoshi; H Matsuda; R Shirakura
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

View more
  14 in total

1.  Chromosome 6 abnormalities correlated with thymoma progression.

Authors:  Hidefumi Sasaki; Yoshitaka Fujii; Nobuyuki Ide
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

2.  Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).

Authors:  Lothar Veits; Gunhild Mechtersheimer; Christina Steger; Jens Freitag; Gregor Mikuz; Kurt W Schmid; Walter Hofmann; Peter Schirmacher; Arndt Hartmann; Ralf J Rieker
Journal:  Virchows Arch       Date:  2011-07-07       Impact factor: 4.064

Review 3.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 4.  Thymic malignancies: from clinical management to targeted therapies.

Authors:  Ronan J Kelly; Iacopo Petrini; Arun Rajan; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2011-11-21       Impact factor: 44.544

5.  HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.

Authors:  Can Küçük; Xiaozhou Hu; Javeed Iqbal; Philippe Gaulard; David Klinkebiel; Adam Cornish; Bhavana J Dave; Wing C Chan
Journal:  Am J Pathol       Date:  2012-11-09       Impact factor: 4.307

6.  Parkin gene alterations in ovarian carcinoma from northern Indian population.

Authors:  Syed Jafar Mehdi; Asgar Ali; M Moshahid Alam Rizvi
Journal:  Pathol Oncol Res       Date:  2011-01-10       Impact factor: 3.201

7.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

8.  Arg and DAP3 expression was correlated with human thymoma stage.

Authors:  Hidefumi Sasaki; Nobuyuki Ide; Haruhiro Yukiue; Yoshihiro Kobayashi; Ichiro Fukai; Yosuke Yamakawa; Yoshitaka Fujii
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

9.  Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.

Authors:  Carmen Spatuzza; Marco Schiavone; Emanuela Di Salle; Elzbieta Janda; Marco Sardiello; Giuseppe Fiume; Olga Fierro; Marco Simonetta; Notis Argiriou; Raffaella Faraonio; Rosanna Capparelli; Ileana Quinto; Giuseppe Scala
Journal:  Nucleic Acids Res       Date:  2008-07-02       Impact factor: 16.971

10.  Genome-wide genetic aberrations of thymoma using cDNA microarray based comparative genomic hybridization.

Authors:  Gui Youn Lee; Woo Ick Yang; Hei Cheul Jeung; Sang Chul Kim; Min Young Seo; Chan Hee Park; Hyun Cheol Chung; Sun Young Rha
Journal:  BMC Genomics       Date:  2007-09-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.